http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201333031-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_581ae3a68286af10919b25930e1f2e34 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
filingDate | 2012-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23c1169045b919af724ca60b1da5474d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e6195bc5d40ffc5ee289f449b403d0f |
publicationDate | 2013-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | TW-201333031-A |
titleOfInvention | The shortest functional anti-enzymatic amino acid fragment with inhibitory alginate decarboxylase and anti-enzyme inhibitor |
abstract | The present invention provides an anti-enzymatic amino acid fragment which is the shortest and has an intact inhibition of alginate decarboxylase and an anti-enzyme inhibitor, and the fragment is the shortest and has a function of making the anti-enzyme function normally, since it is the shortest and has a complete function. An anti-enzymatic amino acid fragment which has minimal toxicity. The present invention further provides a pharmaceutical composition comprising the amino acid fragment, which inhibits cancer and treats cancer by inhibiting an oncoprotein such as avian acid decarboxylase and an enzyme inhibitor. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111840298-A |
priorityDate | 2012-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 675.